Skip to main content
Premium Trial:

Request an Annual Quote

GTG to Sell MMI s Animal Breeds Tests in Australia

NEW YORK, Feb. 27 (GenomeWeb News) - Genetic Technologies and MetaMorphix have entered a strategic alliance that will include jointly marketing and distributing MMI's genetic tests for livestock and pets in Australia and New Zealand, Gene Technologies said today.


In a statement, GTG singled out MMI's genetic polling of cattle and breed-confirmation of dogs as programs to be launched in Australia and New Zealand. MMI has developed tests distinguishing between 35 different purebred dogs, and plans tests for more than 55 more.


The Melbourne, Australia-based genomics firm said in addition to joint commercialization of these programs, the alliance would consider "ways to optimize the geographic advantage" of the two companies' labs in Melbourne and Davis, Ca., respectively.


Financial details were not released.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.